MLO8 is typically produced in E. coli using SUMO fusion vectors to enhance solubility . Key steps include:
Cloning: The MLO8 gene (residues 1–593) is inserted into the pE-SUMO vector .
Purification: SUMO protease cleavage followed by nickel-affinity chromatography .
Yield: ~0.1–1.0 mg/mL post-reconstitution, with >90% purity confirmed via SDS-PAGE .
| Parameter | Details |
|---|---|
| Storage Conditions | -20°C/-80°C in Tris/PBS buffer with 6% trehalose |
| Reconstitution Buffer | Deionized water + 50% glycerol (recommended) |
| Stability | Avoid repeated freeze-thaw cycles |
Recombinant MLO8 is primarily used for:
Antibody Production: As an immunogen for generating anti-MLO8 antibodies .
Structural Studies: NMR or crystallography to resolve transmembrane domain architecture .
Interaction Screens: Yeast two-hybrid assays to identify binding partners (e.g., calmodulin or receptor kinases) .